baber/WOPTO huggingface dataset:
Patent DE-69619134-T2 (DE)
Inventor: PALM LARS-ERIK
IPC: B65B61/24
Filed: 1996-11-05
Granted: 2002-07-18
Abstract: PCT No. PCT/SE96/01420 Sec. 371 Date Jul. 30, 1998 Sec. 102(e) Date Jul. 30, 1998 PCT Filed Nov. 5, 1996 PCT Pub. No. WO97/18995 PCT Pub. Date May 29, 1997Packaging containers for liquid contents, for example milk, are normally manufactured from laminated packaging material including a carrier or core layer of fiber material which is coated on each side with plastic layers. In order to facilitate folding of the material, this is normally provided with a pattern of weakening crease lines which facilitate the reforming into the desired packaging container configuration. A method of retroforming or calibrating a packaging container for realizing more accurate final configuration, sharper fold lines and thereby for imparting to the packaging container improved steadiness and stability comprises the steps of surrounding the packaging container (1) with a forming device (11) adapted to the final configuration of the packaging container, and of displacing parts (12, 13) of the forming device towards one another so that the free space for the packaging container is briefly reduced. An apparatus for carrying the method according to the present invention into effect comprises a forming device (11) with moving forming parts which, in the closed position, define a forming cavity of a volume which amounts to between 100 and 110 per cent of the theoretical minimum volume of a processed packaging container.
Patent DE-69630445-T2 (DE)
Inventor: MANNING E
IPC: A61M60/833
Filed: 1996-04-12
Granted: 2004-07-29
Abstract: A method of treating a subject under cardiac arrest comprises the steps of: blocking the descending aorta of the subject; then withdrawing blood from the subject; oxygenating the blood withdrawn from the subject; and perfusing the aortic arch of the subject with oxygenated blood in an amount effective to deliver oxygen to the heart of the subject. This method enables the subject to continue to receive oxygenating material (i.e., blood in this instance) without the danger of volume overload that would be present if another oxygenated solution were continuously infused.
Patent DE-69631014-T2 (DE)
Inventor: BINI ALESSANDRA
IPC: C07K1/12
Filed: 1996-05-17
Granted: 2004-09-16
Abstract: The invention provides a method of causing the degradation of fibrin(ogen) (i.e., fibrin, fibrinogen, and related substances) by means of a fibrinolytic metalloproteinase, such as MMP-3. The method of the invention may be performed in vitro to provide diagnostic information characterizing fibrin(ogen) and the fibrinolytic physiology. The method may also be performed in vivo as a method of thrombolytic therapy in which a fibrinolytic metalloproteinase is administered to a subject to degrade thrombus in situ. The invention further provides compositions containing a fibrinolytic metalloproteinase for the performance of fibrinolytic or thrombolytic procedures. Also provided are kits which include a fibrinolytic metalloproteinase for performing fibrinolytic or thrombolytic procedures.
Patent DE-69632029-T2 (DE)
Inventor: WEILANDT ANDERS
IPC: A61B10/02
Filed: 1996-01-15
Granted: 2004-08-05
Abstract: A biopsy apparatus comprising a biopsy instrument (20) and means (10) for holding and controlling the biopsy instrument during tissue extraction. The biopsy instrument includes a tube (3) having a finger-like projection at one end and a cannula (4) slidably disposed in the tube. After insertion of the biopsy instrument into a tissue, the tube is displaced on the cannula so that the projection passes through an aperture in the cannula to sever the tissue sample in the cannula bore from the tissue. The projection retains the severed sample in the cannula bore during withdrawal of the biopsy instrument from the tissue. A holding and control assembly (10) having a first and second spring is provided for moving the tube and cannula in a forward direction to penetrate the tissue and then substantially consecutively moving the tube in the forward direction to sever and retain the sample in the cannula bore.
Patent DE-69635564-T2 (DE)
Inventor: MICHELSON GARY KARLIN
IPC: A61B17/56
Filed: 1996-02-26
Granted: 2006-08-31
Abstract: A guarded sleeve system for use in human spinal surgery across the height of a disc space between two adjacent vertebral bodies, comprising: an outer sleeve having an opening for providing protected access to the disc space and at least portions of the adjacent vertebral bodies; and 
at least one extended portion extending from the outer sleeve for insertion into the disc space between the adjacent vertebral bodies, said at least one extended portion having a portion for bearing against each of the adjacent endplates of the adjacent vertebral bodies, said portion of said at least one extended portion having upper and lower surfaces adapted to contact the respective endplates of the adjacent vertebral bodies for properly aligning and distancing apart the adjacent vertebral bodies.
Patent DE-69636167-T2 (DE)
Inventor: GUGLIELMOTTI ANGELO
IPC: A61P21/00
Filed: 1996-10-26
Granted: 2007-03-29
Abstract: PCT No. PCT/EP96/04672 Sec. 371 Date Sep. 3, 1998 Sec. 102(e) Date Sep. 3, 1998 PCT Filed Oct. 26, 1996 PCT Pub. No. WO97/16185 PCT Pub. Date May 9, 1997A pharmaceutical composition comprising an anti-inflammatory drug capable of suppressing the production of cytokines (CSAID) an immunosuppressant and a pharmaceutically acceptable excipient.
Patent DE-69636991-T2 (DE)
Inventor: TOMPKIN WAYNE ROBERT
IPC: G02B5/12
Filed: 1996-11-14
Granted: 2007-12-06
Abstract: An optical information carrier is in the form of a composite laminate having diffractive first relief structures (10) embossed into the underside (4) of the carrier foil (3) to produce visual optical-diffractive effects and optionally diffractive second relief structures (10) embossed into the top side (5) of the carrier foil (3). The top side (5) are provided with an optically effective relief structure (7) formed by layers of a dielectric (9) which form a machine readable information by covering or exposing the relief structure (15) of the underside (4) along a data track. A lacquer layer (29) covers the dielectric layers (9) and the neighbouring parts of the top side (5). The dielectric layers (9) differ in refractive index from the refractive indices of the adjoining materials of the carrier foil (3) and the lacquer layer (29). The materials of the carrier foil (3) and the lacquer layer (29) may have the same refractive index and allow light impinging on the top side (5) to penetrate at least partially into the composite laminate. <IMAGE>
Patent DE-69705512-T2 (DE)
Inventor: KOHL MICHEL
IPC: G01N33/53
Filed: 1997-04-30
Granted: 2002-04-25
Abstract: The invention discloses a method for detecting and/or quantifying a hapten in a homogeneous phase, comprising the following steps: adding a known quantity of a hapten inhibitor complex to the solution containing the hapten to be detected and/or quantified; adding to the solution a quantity of antibodies corresponding to the quantity of the hapten/inhibitor complex; adding to the solution a type C beta-lactamase having an active site for two substrates in antigenic competition in the said active site, the first substrate being a reporter substrate capable of being transformed into a detectable and/or quantifiable product, preferably by visible UV radiation measurement, the second substrate being the hapten/inhibitor complex acting on the hydrolysis rate of the reporter substrate; detecting and/or quantifying the concentration of the product resulting from the transformation of the reporter substrate, the Km constant of the reporter substrate being at least a hundred times higher than the Km constant of the hapten/inhibitor complex, and the kcat constant being at least ten times higher than the Kcat constant of the hapten/inhibitor complex.
Patent DE-69706048-T2 (DE)
Inventor: POHJOLA JORMA
IPC: H01R12/67
Filed: 1997-05-27
Granted: 2002-05-29
Abstract: PCT No. PCT/FI97/00320 Sec. 371 Date Jul. 15, 1999 Sec. 102(e) Date Jul. 15, 1999 PCT Filed May 27, 1997 PCT Pub. No. WO97/45895 PCT Pub. Date Dec. 4, 1997This invention relates to a junction between an intelligent contact terminal (3) and a cable (1, 2), said junction comprising connector pins (4) extending from the contact terminal (3), penetrating into a cable insulation sheath (1) and piercing flat wires (2) included in the cable and provided with lip portions (10) pressing against the lateral faces of the pins. In order to provide a secure contact, the pins (4) are slightly conical or tapered at least within the region of said lip portions (10). By designing the flat wire as a multilayer wire, the lip portions (10) of the wire layers together can be brought to provide an increased contact area. In addition, the multilayer wire (2) is penetrable with a lesser application of force if the cable is provided with preliminary holes for the pins (4).
Patent DE-69706562-T2 (DE)
Inventor: KITAMURA SATOSHI
IPC: A61P25/28
Filed: 1997-12-05
Granted: 2002-05-29
Abstract: PCT No. PCT/JP97/04451 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 5, 1997 PCT Pub. No. WO98/25914 PCT Pub. Date Jun. 18, 1998Hydrates of N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide, which are stable against heat, light, and humidity, are described. The material is easy to handle under ordinary interior humidity conditions. N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate is useful as a medicament in the treatment of amnesia and senile dementia.
Patent DE-69709644-T2 (DE)
Inventor: PUGIN BENOIT
IPC: C07C231/18
Filed: 1997-07-09
Granted: 2002-08-14
Abstract: The invention relates to 1,2-ferrocenyldiphosphines which contain a functional group in the 1' position either directly or via a bridging group, and also a process for their preparation. The compounds are important for transition metal complexes containing d-8 metals such as Rh, Ru, Pd or Ir. These transition metal complexes are widely used in the hydrogenation of organic double or triple bonds, in particular olefinic double bonds and carbon-heteroatom double bonds. The complexes are particularly suitable for enantioselective hydrogenation using chiral ferrocenyldiphosphines and corresponding prochiral unsaturated compounds. Ferrocenyldiphosphines having a functional group in the 1' position are also important intermediates for ferrocenyldiphosphine ligands and their metal complexes of d-8 metals such as rhodium, ruthenium, palladium or iridium which are bound to inorganic polymeric supports via this functional group. These metal complexes bound to an inorganic or organic support material are likewise very suitable for the hydrogenation of organic double or triple bonds.
Patent DE-69709676-T2 (DE)
Inventor: ZOBELE FRANCO
IPC: A61L9/03
Filed: 1997-11-06
Granted: 2002-10-02
Abstract: Heating device for the evaporation of liquid chemical substances,such as insecticides or perfumed essences, of the type comprising a box-shaped body (1) to which a bottle containing said substance and provided with a wick (9) may be associated, said wick partially facing an electric heating element (3) integral with the box-shaped body (1), and in which the relative position of the wick (9) and heating element (3) is adjustable, wherein said bottle is fixed to a sleeve (7) sliding inside a fitting bush (4) integral with the bottom part of the box-shaped body (1), said sleeve (7) having, in the region of its upper edge, a radially projecting stop profile and an operating arm extending through a window formed on the box-shaped body (1).
Patent DE-69710438-T2 (DE)
Inventor: CRISTIN MICHEL
IPC: C05B5/00
Filed: 1997-12-17
Granted: 2002-09-26
Abstract: Production of a calcium phosphate soil improver (I) comprises reacting a slag (II) from steel-making of low phosphorus content with a phosphorus compound (III). (II) and (III) are homogenously mixed by projecting (III) in an injectable particle form into a jet of liquid (II). The metallic iron/ferrous iron (Fe<0>/Fe<2+>) redox equilibrium conditions and proportion of (III) are such that, on cooling, (I) is obtained containing calcium silicate and silicophosphate phases of the larnite ( beta -Ca2SiO4 or 'C2S') and/or '16 C2S, C3P' type, incorporating the phosphorus contained in (III). Also claimed are: (i) an apparatus for the above process comprising a metallurgical container from which (II) is poured as jet of liquid into a receiver while (III) is injected into the jet; and (ii) a product (I') of the process, which contains more than 35 wt.% of calcium phosphate and silico-phosphate phases of the 'C2S' and/or '16 C2S, C3P' type (excluding nagelschmidtite and silico-carnotite phases) having an average phosphorus content (as P2O5) of 6-21.5 %, where more than 90 % of the magnesium contained in (I') is either in the free state or substituted in a wustite.
Patent DE-69714928-T2 (DE)
Inventor: NONOUE TORAHIKO
IPC: A61H1/00
Filed: 1997-09-25
Granted: 2003-04-24
Abstract: A massage machine is provided which is adapted for effective massage by initiating a pair of therapeutic fingers (70) (70) into a lateral movement toward or away from each other approximately simultaneously with the start of an upward or downward movement of the fingers. The massage machine (10) comprises the therapeutic fingers (70) (70) arranged on the backrest (14) of a chair (12), bed or the like for supporting the back of the person to be massaged, lift means for moving the therapeutic fingers upward and downward longitudinally of the backrest, means for laterally moving the therapeutic fingers toward and away from each other, and control means for initiating the therapeutic fingers into a movement toward or away from each other by the laterally moving means approximately simultaneously with the start of an upward movement of the fingers by the lift means and for initiating the fingers into a movement toward or away from each other by the laterally moving means approximately simultaneously with the start of a downward movement of the fingers by the lift means. <IMAGE>
Patent DE-69717097-T2 (DE)
Inventor: BRIGGS ROBERT
IPC: C07C47/12
Filed: 1997-04-23
Granted: 2003-07-24
Abstract: This invention relates in part to processes for producing one or more substituted or unsubstituted 1,6-hexanediols which comprise subjecting one or more substituted or unsubstituted penten-1-ols to reductive hydroformylation in the presence of a reductive hydroformylation catalyst, e.g., a metal-organophosphorus ligand complex catalyst, to produce said one or more substituted or unsubstituted 1,6-hexanediols. The substituted and unsubstituted 1,6-hexanediols produced by the processes of this invention can undergo further reaction(s) to afford desired derivatives thereof, e.g., epsilon caprolactone. This invention also relates in part to reaction mixtures containing one or more substituted or unsubstituted 1,6-hexanediols as principal product(s) of reaction.
Patent DE-69725284-T2 (DE)
Inventor: HOURAHANE DONALD HENRY
IPC: E04C5/07
Filed: 1997-01-15
Granted: 2004-08-19
Abstract: A yarn for use in a cement mortar matrix, includes a core (22) and a multitude of staple fibers (26) forming a layer which envelopes the core (22) and provides an extended surface area and interstical spaces for infiltration by cement fines and hydrates. The staple fibers (26) are spun around the core (22) and attached to the core (22) at spaced areas (30). The staple fibers (26) also have sufficient freedom of radial movement to provide the interstical spaces and permit ingress of cement fines and the formation of hydrates (28) in these spaces.
Patent DE-69734773-T2 (DE)
Inventor: HORWELL CHRISTOPHER
IPC: C07D213/40
Filed: 1997-08-06
Granted: 2006-07-20
Abstract: The compounds of the instant invention are novel compounds of Formula Ior a pharmaceutically acceptable salt thereof wherein Ar is phenyl or pyridyl unsubstituted or substituted. Ar1 can be independently selected from Ar and can also include pyridyl-N-oxide, indolyl, imidazole, and pyridyl; R3 can be independently selected from Ar or is hydrogen, hydroxy, NMe2, N-methyl-pyrrole, imidazole, tetrazole, thiazole (a), (b), (c), or (d), wherein Ar2 is phenyl or pyridyl. The instant compounds antagonize the bombesin receptors in mammals and are therefore effective in treating and/or preventing depression, psychoses, seasonal affective disorders, cancer, feeding disorders, gastrointestinal disorders, inflammatory bowel disease, sleep disorders, and memory impairment.
Patent DE-69737777-T2 (DE)
Inventor: PENN IAN M
IPC: A61F2/915
Filed: 1997-03-05
Granted: 2008-02-07
Abstract: An expandable stent (10) having a proximal end (15) and a distal end (20) in communication with one another. A tubular wall (25) is disposed between the proximal end and the distal end, and has a longitudinal axis. The tubular wall has a porous surface defined by a plurality of intersecting members (30) arranged to define a first repealing pattern comprised of a polygon having a pair of sidewalls (35,40) and substantially parallel to the longitudinal axis, a concave-shaped (50) first wall having a first apex (54), and a convex-shaped (60) second wall having a second apex (64). The first wall and the second wall connect the sidewalls, and at least one of the first apex and the second apex is substantially flat. The first apex and the second apex are of different lengths. The stent is expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force on the stent.
Patent DE-69809362-T2 (DE)
Inventor: LELEU JEAN BERNARD
IPC: A23L27/30
Filed: 1998-09-23
Granted: 2003-09-11
Abstract: New crystalline maltitol forms containing: (a) bipyramidal; (b )prismatic; or (c) a mixture of bipyramidal and prismatic crystals. The bipyramidal-form crystals comprise regular octahedra of square base 50-500 mu m and the prismatic form, of length greater than width (l = 100 - 400 mu m and w = 20 - 100 mu m), comprising tetrahedra. Independent claims are also included for the preparation of: a) compositions containing bipyramidal crystals by the crystallisation of a maltitol syrup with a maltitol content greater than 87 (preferably greater than 96) %, and a maltotriitol content less than 1%; b) compositions containing prismatic crystals by crystallisation of a maltitol syrup with a maltitol content greater than 87 (preferably greater than 96)%, and a maltotriitol content greater or equal to 4%; c) compositions containing bipyramidal and prismatic crystals by crystallisation of a maltitol syrup with a maltitol content greater than 87 (preferably greater than 96)% and a maltotriitol content between 1 - 4%.
Patent DE-69813809-T2 (DE)
Inventor: ASH W
IPC: E02D29/02
Filed: 1998-06-12
Granted: 2004-03-11
Abstract: A retaining wall module (1) comprises a wall panel member (2) having a front and a rear provided with a transverse loop (10) at its rear and a footing member (4) mechanically connected to the panel member (2) by means of engagement with the loop (10). In one embodiment the footing member (4) comprises an elongate base and a head (8) at one end of the base for engagement with the loop (10). Also provided is a retaining wall module comprising a pair of opposing wall panel members (2), each having a front and a rear and provided with a transverse loop (10) at its rear and a footing member (46) extending between the rears of the wall panel members (2) and being mechanically connected to each wall panel member (2) by means of the loops (10).
Patent DE-69813895-T2 (DE)
Inventor: CONNOR THOMAS
IPC: A61P25/28
Filed: 1998-11-04
Granted: 2003-11-06
Abstract: PCT No. PCT/US98/23482 Sec. 371 Date Feb. 7, 2000 Sec. 102(e) Date Feb. 7, 2000 PCT Filed Nov. 4, 1998 PCT Pub. No. WO99/26616 PCT Pub. Date Jun. 3, 1999The present invention provides compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of diseases whose treatment benefits from the inhibition of phosphodiesterase (PDE-IV) or Tumor Necrosis Factor (TNF) including asthma, allergic diseases, rheumatoid arthritis, osteoarthritis, septic shock. The compounds provided by this invention have formula (I) wherein R1, R2, R3, R4 are as defined herein.
Patent DE-69816477-T2 (DE)
Inventor: BONNAIN JEAN-CHRISTOPHE
IPC: B31B50/80
Filed: 1998-09-21
Granted: 2004-05-27
Abstract: A packaging machine for packaging articles into cartons selected from, at least, a first carton or a second carton is described, wherein the first and second cartons are of a different type or size. The cartons are stored in at least one hopper, and picked for packing by a carton engaging means arranged to remove cartons from said at least one hopper and transport them sequentially to a first predetermined position. From there the cartons are transferred to a paper feed chain which transports the cartons to a second predetermined position, from where the cartons are combined with said articles. The paper feed chain comprises a support means carrying a first endless chain from which is depended a first set of guide lugs and a second endless chain from which is depended a second set of guide lugs. The guide lugs are interleaved to produce carton receiving zones, the length of which can be altered, for different carton sizes or types, by altering the relative positions of the first and second set of guide lugs. The support means is movable such that when the relative positions of the lugs is changed, this change can be compensated for such that the position of the first set of lugs with respect to said first predetermined position is unaltered.
Patent DE-69817200-T2 (DE)
Inventor: KOCH M
IPC: H01R24/38
Filed: 1998-09-16
Granted: 2004-06-17
Abstract: An electrical connector including an outer shell, and an integral rotatable cam shell positioned over the outer shell. The cam shell has at least one switch actuating cam extending radially from an outer surface thereof. Upon mating of the connector with a mating connector assembly, the cam shell is rotated to cause the cam to contact a switch and thereby change the switch from an open state wherein current flow through the connector is interrupted to a closed state wherein current is allowed to flow through the connector and the mating connector. Preferably, the connector further includes a spring positioned between the outer shell and the cam shell. The spring biases the cam shell against the outer shell axially in a direction away from the mating connector.
Patent DE-69820449-T2 (DE)
Inventor: UTKU NALAN
IPC: A61K48/00
Filed: 1998-08-28
Granted: 2005-03-10
Abstract: The present invention discloses a T cell immune response cDNA 7 (TIRC7) encoding a T-cell transmembrane protein as well as peptides and polypeptides derived therefrom and antibodies recognizing said (poly)peptides. Also disclosed is the use thereof for the preparation of pharmaceutical compositions for use in organ transplantation, for the treatment of autoimmune, allergic or infectious diseases, or for treatment of tumors. Furthermore, methods for modulating (antigen-specific) T cell unresponsiveness inducing maintaining or reversing T cell unresponsiveness by inhibiting or stimulating an (unresponsive) T cell through the novel TIRC7 membrane protein are encompassed herein.